Summary of ‘Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants’
✍ Scribed by Andrea Milne
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 51 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1557-6272
- DOI
- 10.1002/ebch.65
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background A patent ductus arteriosus (PDA) complicates the clinical course of preterm infants, increasing their risks of developing chronic lung disease (CLD), necrotizing enterocolitis (NEC), and intraventricular hemorrhage (IVH). Indomethacin is used as standard therapy to close
## Abstract These are the characteristics and key findings for a Cochrane review, published in this issue of EBCH, first published as: Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. __Cochrane Database of Systematic Re
## Abstract These are the characteristics and key findings for a Cochrane review, published in this issue of EBCH, first published as: Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. __Cochrane Database of Systematic Reviews__